Nordic Capital Evolution II

About Nordic Capital Evolution II

Nordic Capital Evolution II is a venture capital firm based in Luxembourg, focusing on Pre-Seed stage investments. The fund actively supports founders building innovative solutions in Fintech, Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionLuxembourg

Funding StagePre Seed

Industry Focus

Deep Tech

Fintech

Saas

Investor Signals Profile

active

Sweet Spot

Healthcare/pharma founders with scalable, regulation-ready models

healthcare

pharma

value creation

scalability

Nordic

rare disease

gene therapy

HSV gene therapy

skin disease

Bullish Signals

Active healthcare/pharma investment focusexternal

Gene therapy platform acquisition signals appetitewebsite

Rare skin disease pipeline expanding via M&Awebsite

HSV high-payload gene therapy acquiredwebsite

Replay platform bolsters genetic skin pipelinewebsite

Contrarian Signals

Demanding environment, harder deal barexternal

Niche rare disease focus limits deal volumewebsite

Founder Do's

Show clear value creation roadmap

Highlight regulatory strategy early

Demonstrate scalability in healthcare

Target rare/genetic disease niches

Show platform acquisition potential

Lead with HSV/gene delivery platform angle

Founder Don'ts

Avoid vague scientific claims

Don't underestimate regulatory complexity

Skip sectors outside healthcare/pharma

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View Plans Browse all Signal Profiles →

Fund Overview

Fund Size€2B

Saves0

Website

Key People

Joakim Lundvall